Kyongbo Pharmaceutical Co., Ltd. (214390) Ratios

― Followers

Kyongbo Pharmaceutical Co., Ltd. Ratios

KR:214390's free cash flow for Q2 2026 was ₩0.36. For the 2026 fiscal year, KR:214390's free cash flow was decreased by ₩ and operating cash flow was ₩0.01. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	0.88	1.08	1.15	1.15	1.22
Quick Ratio	0.48	0.53	0.46	0.55	0.62
Cash Ratio	0.04	0.05	0.03	0.04	0.07
Solvency Ratio	0.09	0.08	0.12	0.12	0.13
Operating Cash Flow Ratio	0.06	0.05	<0.01	0.04	0.11
Short-Term Operating Cash Flow Coverage	0.09	0.07	<0.01	0.07	0.16
Net Current Asset Value	₩ -50.68B	₩ -14.66B	₩ 14.21B	₩ 13.98B	₩ 19.48B
Leverage Ratios
Debt-to-Assets Ratio	0.43	0.40	0.32	0.29	0.27
Debt-to-Equity Ratio	1.07	0.87	0.63	0.53	0.45
Debt-to-Capital Ratio	0.52	0.47	0.38	0.34	0.31
Long-Term Debt-to-Capital Ratio	0.14	0.14	<0.01	<0.01	<0.01
Financial Leverage Ratio	2.50	2.20	1.94	1.84	1.67
Debt Service Coverage Ratio	0.11	0.16	0.23	0.24	0.21
Interest Coverage Ratio	0.42	0.82	2.44	1.63	0.83
Debt to Market Cap	1.19	0.91	0.61	0.36	0.26
Interest Debt Per Share	6.87K	5.49K	4.00K	3.32K	2.77K
Net Debt to EBITDA	9.02	7.14	4.04	4.14	4.55
Profitability Margins
Gross Profit Margin	37.24%	37.04%	34.55%	29.15%	22.63%
EBIT Margin	0.94%	1.33%	3.85%	2.58%	0.54%
EBITDA Margin	5.99%	6.33%	9.05%	7.97%	6.51%
Operating Profit Margin	0.94%	1.33%	4.38%	2.56%	0.71%
Pretax Profit Margin	2.14%	0.17%	2.06%	1.00%	-0.31%
Net Profit Margin	1.78%	0.07%	1.94%	1.37%	0.31%
Continuous Operations Profit Margin	1.78%	0.07%	1.94%	1.37%	0.31%
Net Income Per EBT	83.16%	40.56%	94.62%	136.95%	-99.31%
EBT Per EBIT	226.93%	12.77%	46.90%	39.17%	-44.15%
Return on Assets (ROA)	1.35%	0.06%	1.63%	1.12%	0.25%
Return on Equity (ROE)	3.42%	0.13%	3.17%	2.06%	0.42%
Return on Capital Employed (ROCE)	1.51%	2.05%	6.91%	3.75%	0.96%
Return on Invested Capital (ROIC)	0.71%	0.52%	4.09%	2.49%	-0.66%
Return on Tangible Assets	1.37%	0.06%	1.66%	1.13%	0.26%
Earnings Yield	3.75%	0.13%	3.12%	1.47%	0.25%
Efficiency Ratios
Receivables Turnover	3.66	3.96	4.56	3.85	3.86
Payables Turnover	9.35	11.26	10.44	6.73	10.30
Inventory Turnover	2.29	2.05	1.72	2.17	2.64
Fixed Asset Turnover	1.70	2.06	2.39	2.25	2.09
Asset Turnover	0.76	0.83	0.84	0.81	0.82
Working Capital Turnover Ratio	-16.61	16.95	12.92	11.27	9.11
Cash Conversion Cycle	219.86	237.41	256.85	208.78	197.18
Days of Sales Outstanding	99.63	92.08	80.04	94.74	94.54
Days of Inventory Outstanding	159.28	177.75	211.76	168.27	138.08
Days of Payables Outstanding	39.05	32.42	34.95	54.23	35.44
Operating Cycle	258.91	269.83	291.80	263.01	232.61
Cash Flow Ratios
Operating Cash Flow Per Share	499.98	312.30	6.24	202.63	423.59
Free Cash Flow Per Share	-1.84K	-1.43K	-544.86	-252.35	-127.87
CapEx Per Share	2.34K	1.74K	551.09	454.98	551.47
Free Cash Flow to Operating Cash Flow	-3.68	-4.57	-87.35	-1.25	-0.30
Dividend Paid and CapEx Coverage Ratio	0.21	0.17	0.01	0.40	0.70
Capital Expenditure Coverage Ratio	0.21	0.18	0.01	0.45	0.77
Operating Cash Flow Coverage Ratio	0.08	0.06	<0.01	0.06	0.16
Operating Cash Flow to Sales Ratio	0.04	0.03	<0.01	0.02	0.05
Free Cash Flow Yield	-33.21%	-24.74%	-8.76%	-2.98%	-1.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	26.44	756.23	32.05	68.00	399.37
Price-to-Sales (P/S) Ratio	0.47	0.52	0.62	0.93	1.24
Price-to-Book (P/B) Ratio	0.89	0.95	1.02	1.40	1.70
Price-to-Free Cash Flow (P/FCF) Ratio	-2.99	-4.04	-11.42	-33.53	-79.77
Price-to-Operating Cash Flow Ratio	11.00	18.48	997.22	41.75	24.08
Price-to-Earnings Growth (PEG) Ratio	0.02	-7.87	0.57	0.18	-3.69
Enterprise Value Multiple	16.88	15.38	10.93	15.87	23.63
Enterprise Value	283.52B	257.19B	236.01B	273.71B	302.01B
EV to EBITDA	16.94	15.38	10.93	15.87	23.63
EV to Sales	1.01	0.97	0.99	1.27	1.54
EV to Free Cash Flow	-6.45	-7.55	-18.12	-45.37	-98.79
EV to Operating Cash Flow	23.72	34.50	1.58K	56.50	29.82
Tangible Book Value Per Share	5.94K	5.93K	5.95K	5.89K	5.88K
Shareholders’ Equity Per Share	6.15K	6.09K	6.11K	6.04K	6.01K
Tax and Other Ratios
Effective Tax Rate	0.17	0.59	0.05	-0.37	1.99
Revenue Per Share	11.69K	11.06K	9.98K	9.05K	8.21K
Net Income Per Share	207.85	7.64	194.06	124.42	25.54
Tax Burden	0.83	0.41	0.95	1.37	-0.99
Interest Burden	2.27	0.13	0.53	0.39	-0.58
Research & Development to Revenue	0.05	0.07	0.02	0.02	0.02
SG&A to Revenue	0.17	0.22	0.20	0.17	0.12
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	2.40	69.00	0.03	1.63	16.59

Currency in KRW